Opinion Advanced therapy medicinal products: a tsunami in clinical medicine Advanced therapy medicinal products offer life-changing benefits for patients with little to no alternative treatments, but realising their full potential requires action across the entire healthcare system.…Published: 1 June 2026
News MHRA asks for views on rare disease therapy plans The ‘Rare disease therapies regulatory framework’ would incorporate a compressed regulatory pathway, aimed to reduce the cost of developing rare disease therapies and make them more affordable, the MHRA said.…Published: 21 May 2026
Feature ‘Moving the goalposts’: the worrying rise of testosterone replacement therapy Rising prescription rates, illicit supply chains and lack of monitoring and support mean that men could be damaging their health by using testosterone without a formal prescription — and pharmacists may have a role to play in spotting harm.…Published: 30 April 2026
Feature The long road to replacing animals in pharmaceutical research Researchers, regulators and industry are working to develop and implement alternatives to animal testing as part of a new government strategy, but experts warn that it may be impossible to completely phase out animal use entirely.…Published: 23 April 2026
News NHS proposes removing masculinising and feminising hormones as routine treatments for under-18s In consultation documents, NHS England said it had concluded there was not enough evidence to suggest that feminising and masculinising medicines are safe or clinically effective enough for the treatment to be routinely available for children and young people.…Published: 10 March 2026
News Health news round-up: cardiovascular disease, women’s health and the potential for new sepsis treatment A weekly summary of important developments in pharmacy and health news that you may have missed.…Published: 6 March 2026
Opinion The dark side of the ‘miracle jab’: why eating disorder safety cannot be an afterthought As the use of glucagon-like peptide-1 receptor agonists increases, so must our awareness of patients who have an eating disorder or who are at risk of developing one.…Published: 9 February 2026
News Health news round-up: NICE approvals, surveillance data and GLP-1 warnings A weekly summary of important developments in pharmacy and health news that you may have missed.…Published: 30 January 2026
News Health news round-up: new NICE guidance, ‘online hospital’ and the environmental burden of medicines A weekly summary of important developments in health news that you may have missed.…Published: 9 January 2026
News NICE recommends new treatment for highly active relapsing multiple sclerosis Natalizumab, a monoclonal antibody, can be used in its originator form as an injection or in a biosimilar form as an infusion.…Published: 5 January 2026
